24/7 Market News Snapshot 27 Jun 2024 – Vigil Neuroscience, Inc. Common Stock (NASDAQ: VIGL)

June 27, 2024 1:09

Press Release

DENVER, Colo., 27 June, 2024 (247marketnews.com) – (Nasdaq:VIGL) are discussed in this article.
Vigil Neuroscience, Inc. (VIGL) is capturing the attention of investors with a notable surge in pre-market trading, reaching $4.81, signaling a remarkable 27.25% increase from the previous closing price of $3.78. This surge, coupled with a substantial trading volume of 1.0M shares, reflects a strong market sentiment toward the company. Technical analysis suggests a possible continuation of this positive trend, positioning VIGL as a stock of interest today, garnering anticipation for further growth amidst promising market dynamics.

In a strategic move, Vigil Neuroscience, Inc., a prominent player in the pharmaceutical realm, has sealed a significant deal with global healthcare giant Sanofi. Sanofi has committed a substantial $40 million investment in Vigil Neuroscience, Inc.’s common stock at a compelling as-converted price of $7.44 per share. This collaboration extends to an exclusive right of first negotiation for Sanofi to license Vigil Neuroscience, Inc.’s advanced small molecule TREM2 agonist program, featuring the promising asset VG-3927 currently undergoing phase 1 clinical trials.

This groundbreaking agreement signifies a pivotal milestone for both entities, underscoring their joint dedication to advancing innovative pharmaceutical solutions. By combining their strengths and resources, Vigil Neuroscience, Inc. and Sanofi aim to drive the development of novel therapies that cater to unmet medical needs and enhance patient outcomes on a global scale.

The collaboration between Vigil Neuroscience, Inc. and Sanofi underscores their shared vision to revolutionize pharmaceutical innovation and underscores their unwavering commitment to advancing healthcare worldwide. Investors and industry observers are encouraged to follow this transformative partnership closely as it unfolds, poised to shape the future of innovative healthcare solutions.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 Market News, Inc Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.